Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M005332200 on August 8, 2000

J. Biol. Chem., Vol. 275, Issue 44, 34541-34551, November 3, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/44/34541    most recent
M005332200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Nishimoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, Y.
Right arrow Articles by Nishimoto, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Multiple Mechanisms Underlie Neurotoxicity by Different Types of Alzheimer's Disease Mutations of Amyloid Precursor Protein*

Yuichi Hashimoto, Takako NiikuraDagger , Yuko Ito, and Ikuo NishimotoDagger

From the Departments of Pharmacology and Neurosciences, KEIO University School of Medicine, Shinanomachi, Tokyo 160, Japan

We examined a neuronal cell system in which single-cell expression of either familial Alzheimer's disease (FAD) gene V642I-APP or K595N/M596L-APP (NL-APP) in an inducible plasmid was controlled without affecting transfection efficiency. This system revealed that (i) low expression of both mutants exerted toxicity sensitive to both Ac-DEVD-CHO (DEVD) and glutathione ethyl ester (GEE), whereas wild-type APP (wtAPP) only at higher expression levels caused GEE/DEVD-resistant death to lesser degrees; (ii) toxicity by the V642I mutation was entirely GEE/DEVD sensitive; and (iii) toxicity by higher expression of NL-APP was GEE/DEVD resistant. The GEE/DEVD-sensitive death was sensitive to pertussis toxin and was due to Go-interacting His657-Lys676 domain. The GEE/DEVD-resistant death was due to C-terminal Met677-Asn695. APP mutants lacking either domain unraveled elaborate intracellular cross-talk between these domains. E618Q-APP, responsible for non-AD type of a human disease, only exerted GEE/DEVD-resistant death at higher expression. Therefore, (i) different FAD mutations in APP cause neuronal cell death through different cytoplasmic domains via different sets of mechanisms; (ii) expression levels of FAD genes are critical in activating specific death mechanisms; and (iii) toxicity by low expression of both mutants most likely reflects the pathogenetic mechanism of FAD.


* This work was supported in part by grants from Naito Foundation, Brain Science Foundation, Takeda Medical Research Foundation, Takeda Science Foundation, the Ministry of Health and Welfare of Japan, the Ministry of Education, Science, and Culture of Japan and the Organization for Pharmaceutical Safety and Research (OPSR).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 81-3-3359-8909; Fax: 81-3-5363-8428; E-mail: nisimoto@mc.med.keio.ac.jp or niikurat@med.keio.ac.jp.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
Y. Hashimoto, M. Kurita, S. Aiso, I. Nishimoto, and M. Matsuoka
Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor {alpha}/WSX-1/gp130
Mol. Biol. Cell, June 15, 2009; 20(12): 2864 - 2873.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
H. K. Anandatheerthavarada and L. Devi
Amyloid Precursor Protein and Mitochondrial Dysfunction in Alzheimer's Disease
Neuroscientist, December 1, 2007; 13(6): 626 - 638.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
T. Chiba, M. Yamada, Y. Hashimoto, M. Sato, J. Sasabe, Y. Kita, K. Terashita, S. Aiso, I. Nishimoto, and M. Matsuoka
Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to Its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo
J. Neurosci., November 2, 2005; 25(44): 10252 - 10261.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Hashimoto, T. Chiba, M. Yamada, M. Nawa, K. Kanekura, H. Suzuki, K. Terashita, S. Aiso, I. Nishimoto, and M. Matsuoka
Transforming Growth Factor {beta}2 Is a Neuronal Death-Inducing Ligand for Amyloid-{beta} Precursor Protein
Mol. Cell. Biol., November 1, 2005; 25(21): 9304 - 9317.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hashimoto, O. Tsuji, K. Kanekura, S. Aiso, T. Niikura, M. Matsuoka, and I. Nishimoto
The Gtx Homeodomain Transcription Factor Exerts Neuroprotection Using Its Homeodomain
J. Biol. Chem., April 16, 2004; 279(16): 16767 - 16777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. H. Mahabeleshwar, R. Das, and G. C. Kundu
Tyrosine Kinase, p56lck-induced Cell Motility, and Urokinase-type Plasminogen Activator Secretion Involve Activation of Epidermal Growth Factor Receptor/Extracellular Signal Regulated Kinase Pathways
J. Biol. Chem., March 12, 2004; 279(11): 9733 - 9742.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Abe, K. Kouyama, T. Tomita, Y. Tomita, N. Ban, M. Nawa, M. Matsuoka, T. Niikura, S. Aiso, Y. Kita, et al.
Analysis of Neurons Created from Wild-Type and Alzheimer's Mutation Knock-In Embryonic Stem Cells by a Highly Efficient Differentiation Protocol
J. Neurosci., September 17, 2003; 23(24): 8513 - 8525.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, et al.
The Cytoplasmic Domain of Alzheimer's Amyloid-{beta} Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 889 - 902.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. K. Anandatheerthavarada, G. Biswas, M.-A. Robin, and N. G. Avadhani
Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells
J. Cell Biol., April 14, 2003; 161(1): 41 - 54.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wei, X. Wang, and J. W. Kusiak
Signaling Events in Amyloid beta -Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection
J. Biol. Chem., May 10, 2002; 277(20): 17649 - 17656.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hashimoto, T. Niikura, Y. Ito, Y. Kita, K. Terashita, and I. Nishimoto
Neurotoxic Mechanisms by Alzheimer's Disease-Linked N141I Mutant Presenilin 2
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 736 - 745.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Gao and S. W. Pimplikar
The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus
PNAS, December 6, 2001; (2001) 261463298.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Hashimoto, T. Niikura, Y. Ito, H. Sudo, M. Hata, E. Arakawa, Y. Abe, Y. Kita, and I. Nishimoto
Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults
J. Neurosci., December 1, 2001; 21(23): 9235 - 9245.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Matsuda, T. Yasukawa, Y. Homma, Y. Ito, T. Niikura, T. Hiraki, S. Hirai, S. Ohno, Y. Kita, M. Kawasumi, et al.
c-Jun N-Terminal Kinase (JNK)-Interacting Protein-1b/Islet-Brain-1 Scaffolds Alzheimer's Amyloid Precursor Protein with JNK
J. Neurosci., September 1, 2001; 21(17): 6597 - 6607.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Hashimoto, T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, Y. Ito, Y. Kita, M. Kawasumi, K. Kouyama, M. Doyu, et al.
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta
PNAS, May 22, 2001; 98(11): 6336 - 6341.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Niikura, Y. Hashimoto, T. Okamoto, Y. Abe, T. Yasukawa, M. Kawasumi, T. Hiraki, Y. Kita, K. Terashita, K. Kouyama, et al.
Insulin-Like Growth Factor I (IGF-I) Protects Cells from Apoptosis by Alzheimer's V642I Mutant Amyloid Precursor Protein through IGF-I Receptor in an IGF-Binding Protein-Sensitive Manner
J. Neurosci., March 15, 2001; 21(6): 1902 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Gao and S. W. Pimplikar
The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus
PNAS, December 18, 2001; 98(26): 14979 - 14984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement